by Dr. Douglas Denham
At Clinical Trials of Texas, Inc. (CTT), we do medical research on new drugs to treat many different types of diseases. One of these diseases – Fatty Liver Disease — has actually been around for a long time, but there haven’t been any real treatments for it until recently.
Fatty Liver Disease is the abnormal accumulation of fat in the liver, which can cause damage to the liver cells and lead to more severe forms of liver disease. Fatty liver is common in people who have type 2 diabetes. The reason for this is that the two share many of the same causes. Obesity is associated with both diabetes and fatty liver. It makes diabetes harder to control, and since obesity is having too much fat in the body, some of the fat ends up in the liver and causes damage.
Having high blood pressure and high cholesterol is also associated with both diabetes and Fatty Liver Disease. Many of the lifestyle issues that people have can lead to these diseases, too. Smoking, lack of exercise, too much alcohol and poor dietary intake are all risk factors for both diseases.
Fatty liver can be found in people in general, but there is a genetic predisposition in certain Hispanic people that can cause them to have Fatty Liver Disease. Just like diabetes, fatty liver can be found in families with this genetic trait.
The following are preventative steps you can take if you think you may be at risk for Fatty Liver Disease:
- First, go see your doctor and get tested. Blood tests that look at how your liver is performing can be the first clue that something is not right.
- Next, your doctor may order an ultrasound test of your liver to see if there is fat in it. This is a painless test that can tell your doctor how much fat is in your liver.
- If you have abnormal liver function blood tests or ultrasound results suggesting increased fat in your liver, then your doctor can prescribe a weight loss program and diet to follow to help reduce the fat in your liver.
Additionally, at CTT we are currently working with many companies that are trying to develop medications to treat Fatty Liver Disease. If you have risk factors such as obesity, type 2 diabetes, high blood pressure or high cholesterol, call us at 210-949-0122 for a complimentary Fatty Liver Screening or click to schedule yourself.
Douglas Scott Denham, DO, CPI is Medical Director of Clinical Trials of Texas, Inc. (CTT) and is board-certified in family medicine, with more than 25 years of experience treating metabolic diseases such as diabetes, obesity and liver disease.
CTT is a woman-owned local company, founded in 2001. This multitherapeutic site conducts clinical trials across areas important to our community such as diabetes, fatty liver and Alzheimer’s Disease. You can learn more about participating in our trials by visiting SAresearch.com or calling 210-949-0122.